Success sets Brisbane medtech company DoseMe up for U.S. market
It was 2012 and Dr Robert McLeay was chatting to his wife’s colleague at a backyard Brisbane barbecue. While enjoying his burger, McLeay listened intently to a story about a scientific innovation not yet easily available to clinicians, but which should have been.